Cyclical use of tamoxifen and high-dose medroxyprogesterone acetate in advanced estrogen receptor positive breast cancer

[1]  S. Lundgren,et al.  Pharmacokinetics and metabolism of medroxyprogesterone acetate in patients with advanced breast cancer. , 1988, Journal of steroid biochemistry.

[2]  I. Ellis,et al.  Oestrogen receptors in primary and advanced breast cancer: an eight year review of 704 cases. , 1987, British Journal of Cancer.

[3]  S. Lundgren,et al.  The influence of progestins on receptor levels in breast cancer metastasis. , 1987, Anticancer research.

[4]  A. Howell,et al.  Endocrine therapy for advanced carcinoma of the breast: relationship between the effect of tamoxifen upon concentrations of progesterone receptor and subsequent response to treatment. , 1987, Cancer research.

[5]  J. Aisner,et al.  High-dose megestrol acetate in the treatment of postmenopausal women with advanced breast cancer. , 1986, Seminars in oncology.

[6]  F. Cavalli,et al.  Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer. , 1984, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  H. Imura,et al.  Effects of tamoxifen on estrogen and progesterone receptors in human breast cancer. , 1981, Cancer research.

[8]  M. Namer,et al.  Increase of progesterone receptor by tamoxifen as a hormonal challenge test in breast cancer. , 1980, Cancer research.

[9]  H. Mouridsen,et al.  Tamoxifen in advanced breast cancer. , 1978, Cancer treatment reviews.

[10]  R. Rubens,et al.  Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.

[11]  E. Milgrom,et al.  Characterization and assay of progesterone receptor in human mammary carcinoma. , 1977, Cancer research.

[12]  M. Pike,et al.  Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples. , 1977, British Journal of Cancer.

[13]  R. Rubens,et al.  Assessment of response to therapy in advanced breast cancer. , 1977, British Journal of Cancer.